Skip to main content
. Author manuscript; available in PMC: 2018 Feb 21.
Published in final edited form as: Expert Opin Drug Deliv. 2008 Dec;5(12):1357–1376. doi: 10.1517/17425240802583421

Figure 2.

Figure 2

Physical characterization of nimodipine solid dispersion (SD) (50% nimodipine, 40% Eudragit® E100, 10% Plasdone® S630).

PXRD patterns (A): (a) pure NMD; (b) physical mixture; (c) SD; (d) Eudragit® E100; (e) Plasdone® S630, and DSC thermograms (B): (a) Plasdone® S630; (b) Eudragit® E100; (c) SD; (d) physical mixture; (e) pure NMD.

"Reprinted with kind permission from Elsevier, Ref. (76)"